| European Case Law Identifier: | ECLI:EP:BA:1984:G000183.19841205 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 05 December 1984 | ||||||||
| Case number: | G 0001/83 | ||||||||
| Referral: | T 0017/81 | ||||||||
| Application number: | 79100968.1 | ||||||||
| IPC class: | A61K | ||||||||
| Language of proceedings: | DE | ||||||||
| Distribution: | |||||||||
| Download and more information: |
|
||||||||
| Title of application: | - | ||||||||
| Applicant name: | Bayer | ||||||||
| Opponent name: | - | ||||||||
| Board: | EBA | ||||||||
| Headnote: | I. A European Patent with claims directed to the use may not be granted for the use of a substance or composition for the treatment of the human or animal body by therapy. II. A European patent may be granted with claims directed to the use of a substance or composition for the manufacture of a medicament for a specified new and inventive therapeutic application. For corresponding English text see decision G_0005/83 |
||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Interpretation of the EPC Interpretation of the Vienna Convention Therapeutical use claims Second medical indication |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: | |||||||||
